Inovio Pharmaceuticals, Inc. (INO) Presents at 12th Annual Cantor Fitzgerald Global Healthcare Conference Transcript

SA Transcripts 162.14K Followers Follow Inovio Pharmaceuticals, Inc. ( INO ) 12th Annual Cantor Fitzgerald Global Healthcare Conference September 9, 2026 3:20 PM EDT Company Participants Jacqueline Shea - CEO, President & Director Conference Call Participants Eric Schmidt - Cantor Fitzgerald & Co., Research Division Alexa Deemer - Cantor Fitzgerald & Co., Research Division Presentation Eric Schmidt Cantor Fitzgerald & Co., Research Division So Inovio represented by Jacqui Shea, the company's President and CEO. My name is Eric Schmidt. I'm one of the biotechnology analysts at Cantor Fitzgerald, and I'm sharing this fireside chat with my colleague, Alexa Deemer. So Jacqui, thank you for coming. Maybe just high level, I know you've got an important FDA action date coming around the corner, which we're going to get into. But for those less familiar with Inovio, what are the 2-minute highlights? Jacqueline Shea CEO, President & Director Yes. Well, first of all, thanks very much for the invitation. It's nice to be here today. So Inovio is a clinical-stage company. We're focused on developing DNA medicines to help treat and prevent HPV-related diseases, cancer and infectious diseases. As Eric mentioned, we've got a very exciting PDUFA date coming up in a few weeks' time, on the 30th of October, for our lead program, which is INO-3107 for the treatment of recurrent respiratory papillomatosis or RRP. And following on behind that also based on our DNA medicines platform, we have a deep clinical pipeline of other candidates. Question-and-Answer Session Eric Schmidt Cantor Fitzgerald & Co., Research Division So tell us a little bit more about your DNA medicines platform, what that means, what that entails? Jacqueline Shea CEO, President & Director Yes. So DNA medicines have been around for quite a while. And what makes Inovio different is really our delivery system. So we start off by identifying target proteins that we want